By Hendra Lukman 
A significant new body of research emerging from a collaborative effort between the University of Surrey, the John Innes Centre, and Quadram Institute Bioscience is challenging long-held assumptions about vitamin D supplementation. The findings, published in the esteemed journal Nutrition Reviews, indicate that a commonly available form of vitamin D supplement, vitamin D2, may not only be less effective than its counterpart, vitamin D3, but could also actively reduce the body’s levels of the more beneficial vitamin D3. This revelation carries substantial implications for public health recommendations and the dietary supplement industry, particularly in regions like the UK where vitamin D deficiency is a prevalent concern, especially during the winter months.
For many individuals, particularly in northern latitudes like the UK, maintaining adequate vitamin D levels is a constant challenge. The UK government currently recommends a daily intake of 10 micrograms (µg) of vitamin D, a crucial nutrient for bone health, immune function, and overall well-being. This recommendation becomes particularly pertinent during the darker months of the year, from October to March, when the sun’s rays are insufficient for the skin to synthesize vitamin D naturally. Consequently, a vast number of people turn to vitamin D supplements to bridge this nutritional gap.
The market offers two primary forms of vitamin D supplements: vitamin D2 (ergocalciferol), typically derived from plant sources like mushrooms, and vitamin D3 (cholecalciferol), which is biologically identical to the form produced in the human skin when exposed to ultraviolet B (UVB) radiation from sunlight. While both forms are intended to boost overall vitamin D status, this latest research suggests a critical difference in their impact on the body’s endogenous vitamin D3 levels.
Unveiling the Counterintuitive Effect of Vitamin D2
The study, a comprehensive meta-analysis of data from numerous randomised controlled trials, meticulously examined the effects of vitamin D2 supplementation on vitamin D levels in participants. The results were striking: individuals who took vitamin D2 supplements consistently showed a reduction in their circulating levels of vitamin D3 compared to those who did not supplement with D2, or who received a placebo. In a significant proportion of the analyzed trials, the vitamin D3 levels in the D2 supplementation groups actually dipped below those observed in the control groups, suggesting an active interference rather than mere ineffectiveness.
Emily Brown, a PhD Research Fellow and the Lead Researcher on the study from the University of Surrey’s Nutrition, Exercise, Chronobiology & Sleep Discipline, articulated the gravity of these findings. "Vitamin D supplements are undeniably important, especially between October and March, when our bodies simply cannot produce vitamin D from sunlight in the UK," she stated. "However, our discovery that vitamin D2 supplements can actually decrease levels of vitamin D3 in the body is a previously unknown effect of taking these supplements. This study strongly suggests that, after considering individual circumstances, vitamin D3 supplements may offer greater benefits for the majority of individuals over vitamin D2."
This insight challenges the prevailing notion that vitamin D2 and D3 are largely interchangeable in their physiological effects. For years, the assumption has been that both forms contribute to the overall vitamin D pool, with D3 being the "natural" form and D2 a "plant-based" alternative. However, the new research points towards a more complex biochemical interaction, where D2 might be actively displacing or hindering the body’s natural production or retention of D3.
The Role of Vitamin D3 in Immune Defence
The implications of this research extend beyond bone health, touching upon the critical role of vitamin D in immune function. A prior study, published in Frontiers in Immunology and also led by Professor Colin Smith from the University of Surrey, had already begun to cast doubt on the identical roles of vitamin D2 and D3 in immune support. That research proposed that vitamin D3 possesses a distinct modifying effect on the immune system, potentially offering a more robust defence against viral and bacterial pathogens.
Professor Colin Smith elaborated on this crucial aspect: "We have demonstrated that vitamin D3, but not vitamin D2, appears to stimulate the type I interferon signalling system within the body. This system is a cornerstone of our immune defence, acting as a first line of protection against bacteria and viruses. Therefore, maintaining a healthy vitamin D3 status could significantly contribute to preventing infections from gaining a foothold in the body."
The type I interferon response is a critical early-stage defence mechanism that alerts the immune system to the presence of pathogens and initiates a cascade of antiviral and antibacterial processes. If vitamin D3 is uniquely capable of activating this pathway, and vitamin D2 is not, then a deficiency in D3, or a situation where D2 is actively reducing D3 levels, could leave individuals more vulnerable to infectious diseases. This adds another layer of urgency to understanding the optimal form of vitamin D supplementation.
Expert Reactions and Calls for Action
The findings have garnered significant attention from the scientific community. Professor Cathie Martin, a Group Leader at the John Innes Centre, emphasized the practical ramifications of the research. "This meta-analysis underscores the critical importance of ensuring that plant-based vitamin D3 is readily accessible in the UK," she stated, highlighting the potential need for a shift in the sourcing and availability of vitamin D supplements.
The research also aligns with the broader mission of institutions like the Quadram Institute Bioscience, which is dedicated to advancing healthier lives through food innovation. Professor Martin Warren, Chief Scientific Officer at the Quadram Institute, commented on the public health significance of the findings. "Vitamin D deficiency represents a substantial public health concern, particularly during the winter months, with widespread deficiency noted across the UK population," he observed. "This collaborative research effort is directly in line with the Quadram Institute’s mission to enhance the nutrient density of the food we consume, thereby promoting healthier lives. Addressing this issue with the most effective form of vitamin D supplementation or fortification is of paramount importance to the nation’s health."
The collective sentiment from these experts points towards a potential re-evaluation of current public health guidance and the types of vitamin D supplements that are recommended or widely available.
Background and Timeline of Understanding Vitamin D
The journey to understanding vitamin D has been a long and evolving one. Its discovery in the early 20th century was primarily linked to its role in preventing rickets, a debilitating bone disease caused by severe vitamin D deficiency. For decades, the focus remained on its skeletal benefits.
- Early 20th Century: Rickets identified as a deficiency disease, with sunlight and cod liver oil recognized as effective treatments. Vitamin D isolated and its chemical structure elucidated.
- Mid-20th Century: Vitamin D’s role in calcium and phosphorus metabolism understood, solidifying its importance for bone health.
- Late 20th Century – Early 21st Century: Growing awareness of vitamin D’s presence beyond bone health, with research exploring its influence on the immune system, cell growth, and other physiological processes. Vitamin D deficiency recognized as a global health issue.
- 2010s: Increased focus on the distinction between vitamin D2 and D3, with emerging evidence suggesting potential differences in their efficacy and metabolism. Studies begin to explore their specific roles in immune modulation.
- 2020s: The current research from the University of Surrey, John Innes Centre, and Quadram Institute Bioscience emerges, providing robust evidence that vitamin D2 may actively diminish vitamin D3 levels, prompting a significant re-evaluation of supplementation strategies.
This chronological progression highlights how scientific understanding is constantly refined, with new research building upon and sometimes overturning previous assumptions. The distinction between vitamin D2 and D3, once considered a minor detail, has now become a critical area of investigation with direct implications for public health advice.
Supporting Data and Nutritional Context
The meta-analysis involved the examination of data from a substantial number of randomized controlled trials, a gold standard in scientific research for establishing cause and effect. While the exact number of trials and participants was not detailed in the initial release, the methodology suggests a robust statistical foundation for the conclusions drawn. The research focused on measuring serum concentrations of 25-hydroxyvitamin D [25(OH)D], the main circulating form of vitamin D in the body, which is used to assess vitamin D status.
The UK’s specific context amplifies the importance of this research. A report by Public Health England in 2019 indicated that during the autumn and winter months, over 80% of the population has insufficient vitamin D levels. This widespread deficiency necessitates effective supplementation strategies. The current recommended daily intake of 10 µg is a public health measure designed to prevent deficiency in the general population. However, if the recommended supplement form is less effective or even detrimental, the impact of this recommendation could be significantly reduced.
The economic implications are also considerable. The global vitamin D market is a multi-billion dollar industry. If a significant portion of these sales consists of vitamin D2 supplements that are less effective or actively counterproductive, it represents a substantial waste of resources and a missed opportunity to improve public health. Furthermore, the pharmaceutical and food fortification industries will need to consider these findings when developing and marketing vitamin D products.
Broader Impact and Future Directions
The implications of this research are far-reaching. Firstly, it strongly suggests that vitamin D3 should be considered the first-line choice for vitamin D supplementation for the vast majority of individuals, particularly those in regions with limited sun exposure. This recommendation is contingent on individual needs and preferences, but the evidence points towards D3’s superior efficacy.
Secondly, it calls for a review of public health guidelines and recommendations concerning vitamin D intake. Health authorities may need to consider updating advice to reflect the differential efficacy of D2 and D3. This could involve promoting vitamin D3-rich foods and fortified products, as well as prioritizing D3 supplements.
Thirdly, the food industry, particularly those involved in fortification, will need to evaluate their current practices. Ensuring that fortified foods contain vitamin D3 rather than D2 could significantly improve the population’s vitamin D status.
Finally, the research highlights the need for continued investigation into the precise mechanisms by which vitamin D2 and D3 interact with the body and exert their effects. Further studies exploring the specific cellular pathways and metabolic processes involved will be crucial in fully understanding these differences. The development of accessible, plant-derived vitamin D3 sources, as suggested by Professor Martin, is also a key area for future focus.
In conclusion, this groundbreaking research from the University of Surrey, John Innes Centre, and Quadram Institute Bioscience provides compelling evidence that vitamin D2 supplements may not be the benign alternative they were once thought to be. By potentially reducing the body’s levels of the more efficient vitamin D3, and given vitamin D3’s unique role in immune defence, these findings necessitate a critical re-evaluation of how we approach vitamin D supplementation and public health strategies aimed at combating widespread deficiency. The future of vitamin D supplementation likely lies in prioritizing the more effective and beneficial form, vitamin D3.
